USE OF INHIBITORS OF LYN-ASSOCIATED SIGNAL TRANSDUCTION (LAST) IN THE TREATMENT OF PROSTATE CANCER

摘要

The present invention concerns methods for the treatment of prostate cancer by the inhibition of Lyn-kinase associated signal transduction. Preferred in accordance with the invention are inhibitors which comprise sequences derived from specific regions of the Lyn-kinase.